Trial Profile
Multicentre, prospective, assessor-blind, in parallel groups randomised and versus reference marketed product controlled confirmatory trial of the efficacy and safety of Institut Biochimique SA (IBSA) 0.1% betamethasone valerate (BMV) medicated plaster for the treatment of chronic plaque psoriasis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Jun 2011
Price :
$35
*
At a glance
- Drugs Betamethasone valerate (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- 01 Jun 2011 Results published in the American Journal of Clinical Dermatology.
- 20 Feb 2010 New trial record